TrialCancer research communications2022

Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium.

Emma Longley Barber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.